Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

STLA · NYSE

Stellantis N.V.

$4.07 -0.21 (-5.04%)

Company overview

Stellantis N.V. engages in the design, engineering, manufacturing, distribution, and sale of automobiles and light commercial vehicles, engines, transmission systems, metallurgical products, and production systems worldwide. It provides luxury, premium, and mainstream passenger vehicles, pickup trucks, sport utility vehicles, and commercial vehicles, as well as parts and services and retail, dealer financing, leasing, and rental services. The company offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, DS, Dodge, Fiat, Fiat Professional, Jeep, Maserati, Ram, Opel, Lancia, Vauxhall, Peugeot, Teksid, and Comau brand names. It sells its products directly as well as through distributors and dealers. Stellantis N.V. was founded in 1899 and is headquartered in Hoofddorp, the Netherlands.

Sector
Consumer Cyclical
Industry
Auto - Manufacturers
Exchange
NYSE
Market cap
$11.8B
Employees
248,243
Headquarters
Hoofddorp
CEO
Antonio Filosa
Listed
June 9, 2010
P/E
-0.52
Dividend yield
8.64%

Company financials

Revenue
$242B
Gross profit
$39B
Operating income
-$28.9B
EBITDA
-$17.6B
Net income
-$25.3B
EPS
-$7.79
Total assets
$207B
Total debt
$47.9B
Gross margin
16.16%
Net margin
-10.46%
Earnings yield
-191.45%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

3.735.066.387.709.02
STLA 1D NYSE O4.04H4.06L3.93C4.06-0.21 (-5.04%)Vol19.41M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
STLA Stock news Make or Break for Stellantis on Oct. 28: Can FaSTLAne 2030 Help Steer Carmarker From Its 52-Week Low? 24/7 Wall Street
STLA Stock news Stellantis Stock Drops to New 52-Week Low: What's Happening? Benzinga
STLA Stock news Stellantis at Record Low: Turnaround Play or Value Trap? 24/7 Wall Street
STLA Stock news Stellantis Sinks 8% as Q3 Report Nears; Ford Drops 4%, General Motors Slides 3% 24/7 Wall Street
STLA Stock news Prediction: Here's What a $1,000 Investment in Archer Aviation Will Be Worth by 2030 The Motley Fool
STLA Press release Mopar at SEMA 2026: Shifting West Hall Into High Gear Mopar is heading to a new home at the 2026 SEMA (Specialty Equipment Market Association) Show, bringing plenty of passion, performance and... PR Newswire
STLA Stock news Ford Rises 2%, General Motors and Stellantis Edge Higher While Stock Market Sells Off 24/7 Wall Street
STLA Stock news Stellantis testing new diesel-hybrid engine for vans Reuters
STLA Press release Stellantis to Announce Third Quarter 2026 Financial Results on October 28 GlobeNewswire
STLA Stock news Unusual Options Volume Report: STLA, CCXI, GLND Schaeffers Research
STLA Stock news Tesla's Robotaxi Lands in Paris—But Europe's Real Fight Is Over Cheap EVs MarketBeat
STLA Stock news Stellantis to start deployment of STLA One platform with Peugeot brand in France Reuters
STLA Stock news Stellantis CEO sees eventual US EV shift, says auto industry becoming more regional Reuters
STLA Stock news Stellantis Shipments Fall on North America Summer Shutdowns WSJ
STLA Stock news Stellantis Q3 shipments fall 1%, weighed down by North America production halt Reuters
STLA Press release Stellantis Reports Q3 2026 Estimated Consolidated Shipments of 1.3 Million Units, Down 1% Year-Over-Year GlobeNewswire
STLA Stock news Stellantis Bets on Affordable EVs to Rebuild European Market Share Zacks Investment Research
STLA Stock news Stellantis CEO backs level playing field for all carmakers CNBC International TV
STLA Stock news Stellantis CEO urges incentives for carmakers who build in Europe as Chinese rivals gain ground CNBC
STLA Press release Stellantis Unveils Six Concept Cars “The Night Before” the Paris Motor Show GlobeNewswire
FAQ

Questions about Stellantis N.V.

What does Stellantis N.V. do?
Stellantis N.V. engages in the design, engineering, manufacturing, distribution, and sale of automobiles and light commercial vehicles, engines, transmission systems, metallurgical products, and production systems worldwide. It provides luxury, premium, and mainstream passenger vehicles, pickup trucks, sport utility vehicles, and commercial vehicles, as well as parts and services and retail, dealer financing, leasing, and rental services. The company offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, DS, Dodge, Fiat, Fiat Professional, Jeep, Maserati, Ram, Opel, Lancia, Vauxhall, Peugeot, Teksid, and Comau brand names. It sells its products directly as well as through distributors and dealers. Stellantis N.V. was founded in 1899 and is headquartered in Hoofddorp, the Netherlands.
What is STLA's market cap?
Stellantis N.V. (STLA) is a listed stock with a live quote. The latest market cap on this page is $11.8B.
Where is Stellantis N.V. headquartered?
Stellantis N.V. is headquartered in Hoofddorp.
How do I get STLA news from the API?
Call GET /v1/news?tickers=STLA. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does STLA news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for STLA, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the STLA price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.